Naproxen Evolan

Naproxen, the active ingredient in Naproxen Evolan, is a nonsteroidal anti‑inflammatory drug presented as an oral tablet for oral use. It treats mild to moderate pain, inflammatory joint conditions and musculoskeletal discomfort in adults. GNH USA supplies Naproxen Evolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen Evolan is an NSAID that reduces inflammation and pain in several common conditions. - Mild to moderate pain: provides analgesia for headache, toothache, or postoperative discomfort. - Osteoarthritis: helps relieve joint pain and improves functional ability. - Rheumatoid arthritis: reduces inflammatory swelling and joint tenderness. - Musculoskeletal pain: eases strain, sprain and back‑ache symptoms. - Dysmenorrhea: lessens menstrual cramps and associated discomfort.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Elevated blood pressure. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe renal impairment. - Hepatotoxicity with elevated liver enzymes. - Anaphylactic or severe allergic reactions. - Cardiovascular events such as myocardial infarction or stroke.

Before prescribing Naproxen Evolan, consider the following safety measures. - Cardiovascular risk: avoid in patients with recent heart attack or uncontrolled hypertension. - Gastrointestinal history: use cautiously in those with ulcer disease or bleeding disorders. - Renal function: monitor kidney function in patients with chronic kidney disease. - Hepatic impairment: adjust use in individuals with liver disease. - Pregnancy and lactation: assess risk‑benefit; generally avoid in the third trimester. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Naproxen Evolan can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, monitor kidney function. - Diuretics: potential for reduced efficacy and renal effects. - Lithium: NSAIDs can raise lithium levels, requiring serum monitoring.